IFNA17 and COVID-19: In view of the recent findings showing the detrimental effect of neutralizing anti-IFN-Abs in patients with COVID-19, it is important to understand the impact of neutralizing anti-IFN-Abs on “nascent” IFNα produced by challenged pDCs and how this affects healthy B cell differentiation.